| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |